Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5

Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5

Abstract Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD). Osteoprotegerin (OPG), known to regulate bone mass by inhibiting osteoclast differentiation and activation, might also play a role in vascular calcification. Increased circulating OPG l...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gustavo Lenci Marques, Shirley Hayashi, Anna Bjällmark, Matilda Larsson, Miguel Riella, Marcia Olandoski, Bengt Lindholm, Marcelo Mazza Nascimento
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/ddd2f065189e4944b811bc2715871624
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares